Paper Details

Paper Title

Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status.

Paper Journal Title

J Clin Oncol

Paper Citation Count

189

Paper Publication Year

2006

Bio Mention

CA-125, HER, HER dimerization, HER2, OC, OCs, Ovarian cancers, PATIENTS, Pertuzumab, advanced ovarian cancer, diarrhea, pHER2, patients, pertuzumab, phosphorylated HER2, rhuMAb 2C4, tumor, tumor biopsies

Mesh Descriptor

Paper Details

Column Actions

Datasets